Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-04-05
1991-11-12
Doll, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 19, 530331, A61K 3700, A61K 3702, C07K 500
Patent
active
050648144
ABSTRACT:
Disclosed are novel peptide and pseudopeptide derivatives and phrmaceutical compositions thereof that inhibit platelet aggregation and thrombus formation in mammalian blood.
REFERENCES:
patent: 3821188 (1979-06-01), McKinley et al.
patent: 4683291 (1987-07-01), Zimmerman et al.
Cheresh et al., "Biosynthetic & Func. Prop. of Arg-Gly Asp.", J. Biol. Chem., vol. 262, #36 12/25, pp. 17703-17711 (1967).
Fujimura, "Von Willebrand Factor", J. Biol Chem. v ol. 261 #1, 1/5 pp. 38-85 (1986).
Humphries et al., "Synthetic peptide from fibronectin", p. 467 Science, vol. 233 (1986).
Klein Scott I.
Molino Bruce F.
Balogh Imre (Jim)
Doll John
Nicholson James A.
Pili-Curtis Carmen
Rhone-Poulenc Rorer Pharmaceuticals Inc.
LandOfFree
Anti-thrombotic peptide and pseudopeptide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-thrombotic peptide and pseudopeptide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-thrombotic peptide and pseudopeptide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1013136